FIELD: biotechnology.
SUBSTANCE: invention is a method of prevention of colibacillosis in calves, including double intramuscular administration of a vaccine against animal colibacillosis to cows 1.5–2 months before delivery with the simultaneous use of tissue biostimulator ASD-2f in a ratio of trivit 1:10: the first dose is 10 cm3, the second dose is 15 cm3, which is administered intramuscularly at a dose of 10.0 ml/head. Colostrum from cows in the experimental group has high protective properties, since the content of immunoglobulin G was significantly higher than in the control groups. In seven-day-old calves born from mothers who received the vaccine + ASDf2 with Trivit, the indicators of cellular and humoral immunity were significantly higher compared to those in calves of the second group (vaccine) and the third group (unvaccinated).
EFFECT: when applying the proposed method of the prevention of colibacillosis, 100% birth rate and safety of calves were obtained.
1 cl, 5 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREVENTION OF COLIBACILLOSIS IN CALVES | 2016 |
|
RU2612081C1 |
METHOD FOR PREVENTING COLIBACTERIOSIS IN CALVES | 2004 |
|
RU2275935C1 |
METHOD FOR PREVENTING GASTROINTESTINAL DISEASES IN CALVES | 2005 |
|
RU2295975C1 |
METHOD FOR PREVENTING THE CASES OF CALVE COLIBACTERIOSIS | 2005 |
|
RU2276994C1 |
COLIBACTERIOSIS AND SALMONELLOSIS PREVENTION METHOD IN PIGLETS | 2008 |
|
RU2358758C1 |
METHOD FOR PREVENTING OMPHALITIS IN CALVES | 2006 |
|
RU2301060C1 |
METHOD FOR PREVENTING OMPHALOPHLEBITIS IN NEONATAL CALVES | 2006 |
|
RU2320350C1 |
METHOD FOR PREVENTION OF OMPHALOPHLEBITIS AND NAVEL GANGRENE IN NEWBORN CALVES | 2007 |
|
RU2333748C1 |
ASSOCIATED VACCINE AGAINST ANAEROBIC ENTEROTOXEMIA AND COLIBACILLOSIS DIARRHEA IN CALVES | 2010 |
|
RU2428202C1 |
VACCINE AGAINST ESCHERICHIOSIS IN ANIMALS | 1993 |
|
RU2043771C1 |
Authors
Dates
2023-12-22—Published
2023-02-17—Filed